End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012

INTRODUCTION: Although the management of scleroderma continues to evolve, it is unknown whether the burden of end-stage kidney disease (ESKD) treated with maintenance renal replacement therapy from SD has changed. METHODS: We examined United States Renal Data System data (n = 1,677,303) for the year...

Descripción completa

Detalles Bibliográficos
Autores principales: Sexton, Donal J., Reule, Scott, Foley, Robert N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762953/
https://www.ncbi.nlm.nih.gov/pubmed/29340325
http://dx.doi.org/10.1016/j.ekir.2017.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762953/
https://www.ncbi.nlm.nih.gov/pubmed/29340325
http://dx.doi.org/10.1016/j.ekir.2017.09.003

Ejemplares similares